Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnimalcare Grp Regulatory News (ANCR)

Share Price Information for Animalcare Grp (ANCR)

Share Price is delayed by 15 minutes
Get Live Data
331.50    0.00 (0.00%)
Bid:
330.00
Ask:
333.00
Spread: 3.00 (0.909%)
Market Cap: £228.89m
ANCR Live PriceLast checked at - London Stock Exchange

Intraday Animalcare Grp Share Chart

Form 8.5 (EPT/RI)

24 Jun 2026 10:38

RNS Number : 5869J
Panmure Liberum Limited
24 June 2026
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Panmure Liberum Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Animalcare Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Animalcare Group plc

(d) Date dealing undertaken:

23 Jun 2026

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

20p ordinary

Purchase

3,514

3.32351 GBP

3.3233 GBP

20p ordinary

Sales

25,000

3.325 GBP

3.325 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing, or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

24/06/2026

Contact name:

Shivani Ghiraiya

Telephone number:

+44 (0) 20 3100 2213

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERFZGZVLDVGVZG
Date   Source Headline
10th Oct 20247:00 amRNSNotification of Major Holding in Company
9th Oct 20248:00 amRNSInvestor Presentation via Investor Meet Company
24th Sep 20247:00 amRNSInterim Results for six months ended 30 June 2024
24th Jul 20247:00 amRNSH1 Trading Update and Notice of Interim Results
20th Jun 20244:57 pmRNSResult of 2024 AGM and Board Changes
31st May 20247:00 amRNSTotal Voting Rights - 31 May 2024
22nd May 20245:41 pmRNSNotification of Major Holding in Company
21st May 20244:49 pmRNS2023 Annual Report and Notice of 2024 AGM
21st May 20243:50 pmRNSNotification of Holding in Company
16th May 20247:00 amRNSPDMR dealing, Admission and Total Voting Rights
15th May 20247:00 amRNSExercise of Options and Total Voting Rights
25th Apr 20247:00 amRNSGrant of options and PDMR Dealing
11th Apr 20242:57 pmRNSSale of equity in STEM Animal Health Inc.
9th Apr 20248:22 amRNSInvestor presentation via Investor Meet Company
9th Apr 20247:00 amRNSPreliminary Unaudited Full Year Results 2023
28th Feb 20247:00 amRNSDisposal of Identicare Ltd
29th Jan 202410:27 amRNSNotification of Major Holding
25th Jan 20247:00 amRNSTrading Update and Notice of 2023 FY Results
9th Nov 20232:01 pmRNSNotification of Major Holding
1st Nov 202311:38 amRNSNotification of Major Holding
12th Oct 20231:28 pmRNSExercise of Options and Total Voting Rights
5th Oct 20237:00 amRNSPDMR Dealing – Dividend Reinvestment Plan
2nd Oct 20234:42 pmRNSNotification of Major Holding
26th Sep 20237:00 amRNSInterim Results for six months ended 30 June 2023
19th Sep 20239:04 amRNSNotification of Major Holding
18th Sep 20236:23 pmRNSNotification of Major Holding
27th Jul 20237:00 amRNSHalf year Trading Update and Notice of Interims
21st Jun 20237:00 amRNSOption Exercise, Admission and Total Voting Rights
13th Jun 20233:50 pmRNSResult of 2023 AGM
19th May 20237:00 amRNS2022 Annual Report and Notice of 2023 AGM
28th Mar 20237:00 amRNS2022 Preliminary Results
26th Jan 20237:00 amRNSTrading Update and Notice of Full Year Results
21st Dec 20223:43 pmRNSNotification of Major Holding
21st Nov 20223:39 pmRNSNotification of Major Holding
14th Nov 20227:00 amRNSChange of Registered Office
20th Oct 20227:34 amRNSCorrective announcement - H1 2022 Interim Results
27th Sep 20227:00 amRNSInterim results for six months ended 30 June 2022
26th Jul 20227:00 amRNSH1 Trading Update and Notice of Interim Results
7th Jun 20225:11 pmRNSResult of 2022 AGM and changes to Board Committees
12th May 20227:00 amRNS2021 Annual Report and Notice of 2022 AGM
3rd May 20227:00 amRNSChanges to Board of Directors
29th Apr 20222:19 pmRNSGrant of options and PDMR Dealing
12th Apr 20221:40 pmRNSNotification of Major Holding
29th Mar 20227:00 amRNSFull year results 2021
24th Mar 20227:00 amRNSAnimalcare and Orthros form VHH R&D collaboration
10th Feb 20222:46 pmRNSAppointment of Non-Executive Director
25th Jan 20227:00 amRNSTrading Update & Notice of Full Year Results
8th Nov 20211:27 pmRNSGrant of options
26th Oct 20219:27 amRNSNotification of Major Holding
5th Oct 20213:22 pmRNSNotification of Major Holding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.